Osmind Raises $40M in Series B Funding

Osmind, San FranciscoCA-based public corporation for the benefit of patients and researchers, whose goal is to develop life-saving treatments for mental illness. in Series B funding.

Theround, which brings the total amount to $57m since the founding in2020 was led by DFJ GrowthParticipation form Susa Ventures, Lachy Groom, Brent Saunders, Helena Goodman Ariel Katz, General Catalyst, Future Ventures, Tiger Global, Pear VC. Justin Kao, partner at DFJ Growth, and the cofounder of Helix, will join Osmind BoardOf Directors.

TheThe company plans to use the funds for continued development and scaling of its electronic health record (EHR), which is used to treat mental health research and treatment. It also plans to advance research with new partners and double the size and reachability of its team virtually and at its headquarters. San Francisco office.

LedBy CEO Lucia Huang, and COO Jimmy Qian, Osmind is a public benefit corporation that helps the medical community administer, track, and study the efficacy of interventions such as ketamine, SPRAVATO®, and transcranial magnetic stimulation for the 14 million U.S. patients living with moderate and serious mental illness. 

The OsmindEHR platform is tailored to the needs mental health clinicians, including psychiatrists, with tools like streamlined charting workflows. Secure patient engagement and automated outcomes tracking. CliniciansThese are also part the Osmind research program, which works with scientists to conduct clinical trials and analyze anonymized, aggregated real-world information to advance new diagnostics, therapeutics, and precision medicine approaches.



Leave a Comment